ETFs Holding ACHN »    ACHN Historical Stock Prices »
ACHN News Video: Fri, Jun 2, 2017, 1:58 PM — Friday's ETF Movers: XBI, XOP

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Achillion Pharmaceuticals is a biopharmaceutical company engaged in the discovery and development of small molecule drug therapies for infectious diseases and immune system disorders. Co. is developing small molecules that will target complement factor D, an essential protein within the amplification loop of the alternative pathway of the complement system. The alternative pathway plays a role in a number of diseases including conditions such as paroxysmal nocturnal hemoglobinuria and C3 glomerulopathy. Co. has also granted to Janssen Pharmaceuticals, Inc. worldwide rights to develop and commercialize a portfolio of antiviral drug candidates for the treatment of chronic hepatitis C virus. Self directed investors in Achillion Pharmaceuticals Inc will be interested in keeping up with all Achillion Pharmaceuticals Inc news they can find, both ACHN news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on ACHN. At RediNews, we simplify this task by presenting both ACHN news releases originating from Achillion Pharmaceuticals Inc itself, and ACHN news from a variety of media outlets. Visitors can browse this news online and through our ACHN RSS news feed.


ACHN News — Articles, Videos, & Press Releases

Add Up The Pieces: VB Could Be Worth $159
Tuesday, February 6, 2018, 8:28 AM — ETF Channel
First Week of ACHN September 21st Options Trading
Thursday, January 25, 2018, 11:26 AM — Stock Options Channel
Actinium Posts Positive DMC View on Lomab-B Phase III Trial
Thursday, December 28, 2017, 8:45 AM — Zacks
Horizon Pharma Gets FDA Nod for Procysbi Label Expansion
Thursday, December 28, 2017, 8:21 AM — Zacks
Insys' Cannabidiol Gets Fast Track Designation in the U.S.
Wednesday, December 27, 2017, 10:29 AM — Zacks
Agios (AGIO) Files NDA for Leukemia Candidate in the U.S.
Wednesday, December 27, 2017, 8:08 AM — Zacks
Alexion's (ALXN) Soliris Label Expansion Approved in Japan
Wednesday, December 27, 2017, 7:11 AM — Zacks
BioMarin's (BMRN) Pegvaliase Review Period Extended by FDA
Tuesday, December 26, 2017, 8:17 AM — Zacks
First Week of February 2018 Options Trading For Achillion Pharmaceuticals (ACHN)
Thursday, December 21, 2017, 10:54 AM — Stock Options Channel
Achillion's Renal Disease Candidate Gets Orphan Drug Status
Tuesday, December 19, 2017, 9:42 AM — Zacks
We Did The Math XBI Can Go To $111
Monday, December 18, 2017, 8:28 AM — ETF Channel
Allergan Inks Deal to Buy Texas-Based Repros Therapeutics
Wednesday, December 13, 2017, 2:46 PM — Zacks
Merck's Keytruda Gets FDA Priority Review for Rare Lymphoma
Tuesday, December 12, 2017, 4:58 PM — Zacks
Short Interest Moves 18.3% Lower For ACHN
Tuesday, December 12, 2017, 1:54 PM — Market News Video
Revance's Neuromodulator Injection Positive in Phase III
Wednesday, December 6, 2017, 1:10 PM — Zacks
AstraZeneca's COPD Drug Succeeds in Label Expansion Study
Tuesday, December 5, 2017, 8:32 AM — Zacks
Pfizer Wins China & Asia-Pacific Rights to Anti-Fungal Drug
Monday, December 4, 2017, 8:03 AM — Zacks
Celldex Begins Phase I Trial on Cancer Candidate CDX-1140
Friday, December 1, 2017, 4:51 PM — Zacks
Merck Announces $10 Billion Buyback, Hikes Dividend by 2.1%
Wednesday, November 29, 2017, 10:53 AM — Zacks
AstraZeneca Files for Label Expansion of Tagrisso in Japan
Tuesday, November 28, 2017, 8:32 AM — Zacks
Glaxo (GSK) Files for U.S. Label Expansion of COPD Inhaler
Thursday, November 23, 2017, 8:12 AM — Zacks
Puma Inks License Deal to Commercialize Cancer Drug Nerlynx
Thursday, November 23, 2017, 7:42 AM — Zacks
Agios Posts New Data on Glioma Candidate from Dose Expansion
Monday, November 20, 2017, 2:42 PM — Zacks
First Week of June 2018 Options Trading For Achillion Pharmaceuticals (ACHN)
Thursday, November 16, 2017, 10:33 AM — Stock Options Channel
Notable Wednesday Option Activity: NGVC, ACHN, SQ
Wednesday, November 15, 2017, 3:26 PM — Stock Options Channel
Commit To Buy Achillion Pharmaceuticals At $3, Earn 12.9% Annualized Using Options
Thursday, October 26, 2017, 11:30 AM — Stock Options Channel
Notable Monday Option Activity: PII, ACHN, WFT
Monday, October 23, 2017, 3:22 PM — Stock Options Channel
How The Parts Add Up: XBI Headed For $103
Thursday, August 24, 2017, 8:39 AM — ETF Channel
Noteworthy Monday Option Activity: ACHN, FEYE, UCTT
Monday, July 31, 2017, 3:26 PM — Stock Options Channel
March 2018 Options Now Available For Achillion Pharmaceuticals (ACHN)
Monday, July 24, 2017, 11:39 AM — Stock Options Channel
Notable Friday Option Activity: HA, PBH, ACHN
Friday, June 2, 2017, 3:32 PM — Stock Options Channel
The Math Shows PXSG Can Go To $33
Tuesday, May 30, 2017, 8:32 AM — ETF Channel
Interesting ACHN Put And Call Options For July 21st
Thursday, May 25, 2017, 10:49 AM — Stock Options Channel
Interesting ACHN Put And Call Options For December 15th
Tuesday, April 25, 2017, 11:17 AM — Stock Options Channel
Peek Under The Hood: VHT Has 11% Upside
Tuesday, April 25, 2017, 9:37 AM — ETF Channel
Look Under The Hood: VBK Has 10% Upside
Wednesday, March 22, 2017, 8:31 AM — ETF Channel
Will Insiders Be Tempted To Buy More ACHN At The New 52-Week Low?
Friday, February 24, 2017, 2:06 PM — Market News Video
ACHN is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:

CHE News
VAR News
PMC News
EBS News
A News
MTD News

RediNews invites those seeking web page financial content for any internet portal, especially any vertical portal specializing in the markets where there is a web page for business, web page for markets, web page finance, etc., to integrate our free web site content, our RSS news feeds. These RSS feeds are found throughout our website wherever news and custom stock content is found, by clicking the RSS icon for any news page (which will look like this): . This dynamic financial content is ideal for sites that already feature stock data content such as historical stock price information whether in the form of a historical stock price table or a web page chart image, to supplement the other custom stock market content displayed.

ACHN News | | Copyright © 2013 - 2018, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.